High Net Worth Advisory Group
RVMD icon

High Net Worth Advisory Group’s Revolution Medicines RVMD Stock Holding History

High Net Worth Advisory Group’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$411K Hold
2,000
– – 0.09% 178
2026
Q2 		$375K Buy
+2,000
New +$292K 0.08% 186
2023
Q1 		– Sell
-2,000
Closed -$47.6K – 498
2022
Q4 		$47.6K Hold
2,000
– – 0.02% 335
2022
Q3 		$39K Buy
+2,000
New +$44K 0.02% 365

Other funds holding RVMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

High Net Worth Advisory Group's RVMD Position: Q3 2026 in Review

High Net Worth Advisory Group held its Revolution Medicines (RVMD) position steady in Q3 2026 at 2,000 shares worth $411K. The position accounts for 0.09% of the portfolio, ranked #178.

High Net Worth Advisory Group first reported a position in RVMD in Q3 2022 and has held it in 4 quarters since. 490 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • High Net Worth Advisory Group held 2,000 shares of Revolution Medicines worth $411K as of Q3 2026.
  • High Net Worth Advisory Group left its Revolution Medicines share count unchanged in Q3 2026.
  • Revolution Medicines made up 0.09% of High Net Worth Advisory Group's portfolio in Q3 2026, its #178 holding.
  • High Net Worth Advisory Group first reported a position in Revolution Medicines in Q3 2022 and has held it in 4 quarters since.
  • 490 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on High Net Worth Advisory Group's 13F filing for Q3 2026, filed 26 Oct 2026.